PT - JOURNAL ARTICLE AU - Petlansky, Rebecca L AU - Bekoe-Tabiri, Amadea D AU - Bueno, Vanessa N AU - Onwuka, AnnMarie N AU - Gionfriddo, Michael R AU - Piper, Brian J TI - Conflicts of Interest of Pediatric Journal Authors AID - 10.1101/2021.05.22.21257647 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.22.21257647 4099 - http://medrxiv.org/content/early/2021/05/24/2021.05.22.21257647.short 4100 - http://medrxiv.org/content/early/2021/05/24/2021.05.22.21257647.full AB - The Physician Payments Sunshine Act requires disclosure of payments made by drug and medical device manufacturers to physicians or teaching hospitals. Academic literature extensively documents gender disparities in the medical profession with regard to salary, promotion, and government funded research. This investigation sought to quantify potential conflicts of interest (CoIs) in pediatric medical journals, specifically examining sex differences. To identify potential CoIs, we examined manuscripts published prior to 2019 in six pediatric journals (JAMA Pediatrics, Pediatrics, The Journal of Pediatrics, Pediatric Blood and Cancer, Pediatric Critical Care Medicine, and The Pediatric Infectious Disease Journal). We collected physician demographics and specialty from the National Plan and Provider Enumeration System National Provider Identifier Registry and compensation data from both ProPublica’s Dollars for Docs (PDD) and Centers for Medicare and Medicaid Services Open Payments (CMSOP). Data was collected on 2,747 authors from 929 manuscripts. Of the 1,088 authors based in the United States with medical degrees (40.5% female), 510 (46.9%) had entries in PDD and CMSOP. Overall, 11,791 payments to these physician-authors totaled $9,586,089.97. Males were 19.6% more likely to receive payments (RR = 1.20, 95% CI [1.05, 1.37], p = 0.008). The mean amount received by males was $23,250.71 while that received by females was $10,970.78 (mean difference = 12,279.92, 95% CI = (2036.31, 22,523.54), p = 0.019). A comprehensive understanding of these CoIs can inform the disclosure policies of journals to promote transparency of authors.Competing Interest StatementBJP is part of an osteoarthritis research team supported by Pfizer and Eli Lilly. The other authors have no disclosures.Funding StatementNo direct external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Procedures were approved as exempt by the Institutional Review Board of Geisinger.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data obtained in this study is publicly available. https://projects.propublica.org/docdollars/ (CoI)Conflict of Interest(CMSOP)Centers for Medicare and Medicaid Services Open Payments(PDD)ProPublica’s Dollars for Docs